Filter
744
Text search:
drug
manufacturing
Featured
Recommendations
60
New Publications
187
Language
Document type
No document type
360
Studies & Reports
141
Guidelines
129
Manuals
44
Strategic & Response Plan
41
Fact sheets
11
Situation Updates
9
Training Material
3
Resource Platforms
3
Infographics
2
Brochures
1
Countries / Regions
Global
37
India
35
Kenya
32
Nigeria
21
Ghana
21
Uganda
19
Ethiopia
17
Sierra Leone
13
Tanzania
13
South Africa
13
Western and Central Europe
13
Nepal
12
Zambia
12
Bangladesh
12
Africa
11
Malawi
9
Botswana
9
Liberia
8
Zimbabwe
8
Ukraine
8
Lesotho
8
Rwanda
7
Namibia
7
Myanmar / Burma
7
South–East Asia Region
7
Philippines
6
Indonesia
5
Latin America and the Carribbean
5
Eastern Europe
5
Eswatini/ Swaziland
4
Haiti
3
Cambodia
3
Thailand
3
East and Southern Africa
3
West and Central Africa
3
Albania
3
Tajikistan
3
Russia
3
Senegal
2
Cameroon
2
Pakistan
2
Germany
2
Mozambique
2
Sudan
2
Western Pacific Region
2
Asia
2
Laos
2
Moldova
2
Vietnam
2
Guinea
1
Congo, Democratic Republic of
1
USA
1
South Sudan
1
Syria
1
China
1
Benin
1
Brazil
1
Serbia
1
Madagascar
1
Sri Lanka
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Solomon Islands
1
Uzbekistan
1
Australia
1
Turkmenistan
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
303
Clinical Guidelines
58
Pharmacy & Technologies
33
Public Health
27
Key Resources
20
Women & Child Health
13
Capacity Building
6
Toolboxes
Pharmacy
83
AMR
81
COVID-19
53
HIV
46
TB
38
Mental Health
34
Malaria
23
NTDs
20
Planetary Health
16
Ebola & Marburg
14
NCDs
13
Health Financing Toolbox
12
Rapid Response
11
Global Health Education
11
Conflict
5
Specific Hazards
5
Caregiver
5
2.0 Rapid Response
5
Cholera
3
Natural Hazards
3
Polio
2
Disability
1
Refugee
1
Zika
1
Antimicrobial resistance (AMR) is a global threat that requires urgent collaborative action within and among countries. AMR makes standard treatments ineffective and facilitates the spread of antimicrobial resistant infections rendering communities vulnerable. The Ministry of Health (MOH) and Minist
...
Technology landscape
The Primary Care Innovator’s Handbook
recommended
Voices from Leaders in the Field
Afr J Thoracic Crit Care Med 2021;27(4):Published online 22 October 2021. https://doi.org/10.7196/AJTCCM.2021.v27i4.173
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines.
Guidelines for Handling Temperature Sensitive Vaccines and Pharmaceuticals
Responses to epidemics, emergencies and disasters raise many ethical issues for the people involved, including public health specialists and policy makers. This training manual provides material on ethical issues in research, surveillance and patient care in these difficult contexts.
Antimicrobial resistance (AMR) both in human and veterinary medicine has reached alarming levels in
most parts of the world and has now been recognized as a significant emerging threat to global public
health and food security. In June 2015, the Food and Agriculture Organization of the United Nati
...
Transforming the Quality of Health Care in Ethiopia
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products
...
Early-warning indicators to prevent stock-outs and overstocking of antiretroviral, antituberculosis and antimalaria medicines.
Accessed Febr. 6, 2020
ຢາຕ້ານເຊື້ອຈຸລະຊີບ (Antimicrobial medicines) ມີຄວາມສໍາຄັນຫຼາຍຕໍ່ວຽກງານການແພດ, ສາທາລະນະສຸກ, ສຸຂະພາບສັດ ແລະ ການຜະລິດອາຫານ. ເນ
...
Saúde Soc. São Paulo, v.30, n.1, e200450, 2021
Desde março de 2020, quando a Organização Mundial de Saúde declarou que o mundo vivia uma pandemia de covid-19, acompanhamos um quadro sanitário sem precedentes nos últimos 100 anos. As medidas atuais contra a
...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o
...
